Big CROs losing out as complex trials favour Phase I specialists
Phase I-focused CROs are winning business from larger rivals as sponsors seek specialists to run more complex studies, market research found.
Archives for September 11, 2011
Sareum sees hike in share prices thanks to inhibitor
Shares in drug discovery company Sareum have soared by 36 per cent after the firm announced the selection of a preclinical development candidate for its Checkpoint kinase 1 (Chk1) inhibitor programme.
Gerresheimer Regensburg expands China facility
Gerresheimer Regensburg GmbH has announced plans to increase production of its medical injection moulders four-fold in its China facility over the next 18 months.
Lonza and Fosun strike up joint venture in Shanghai
Lonza Group and Fosun Pharmaceuticals will pump $15.6m (100m yuan) into a joint venture in the Zhangjiang High-Tech Industry Zone, China.
Lanxess set to increase thionyl chloride production in Indian facility
Lanxess have begun plans to increase its production of thionyl chloride by 20 per cent at its plant in Nagda, India.
Advanced Pharma CR relocates to larger site in line with demand
Florida, US-based Advanced Pharma CR says decision to move to University of Miami Life Science and Technology Park (UMLSTP) was driven by demand.